Get the Stockscreener App
3.71
2.11%
-0.08
Femasys Inc stock is traded at $3.71, with a volume of 35,265.
It is down -2.11% in the last 24 hours and up +1.09% over the past month.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
See More
Previous Close:
$3.79
Open:
$3.8
24h Volume:
35,265
Relative Volume:
0.60
Market Cap:
$11.20M
Revenue:
$2.38M
Net Income/Loss:
$-12.40M
P/E Ratio:
-0.5741
EPS:
-6.4626
Net Cash Flow:
$-18.68M
1W Performance:
+23.26%
1M Performance:
+1.09%
6M Performance:
-70.33%
1Y Performance:
-79.73%
1-Day Range:
$3.59
$3.92
1-Week Range:
$3.05
$4.22
52-Week Range:
$2.895
$22.20
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys Inc
Sector
Industry
Phone
770-500-3910
Address
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
3.71 | 11.20M | 2.38M | -12.40M | -18.68M | -6.4626 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-25 | Initiated | Laidlaw | Buy |
Femasys Inc Stock (FEMY) Latest News
FEMY|Femasys Inc|Price:3.710|Chg%:-0.080 - TradingKey
Femasys Inc (FEMY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FEMY Price Today: Femasys Inc. Stock Price, Quote & Chart | MEXC - mexc.co
Femasys Inc. (FEMY) Hovers Near Support Amid Modest Pullback – Key Levels in FocusVolume Spike Alerts - dars.gov.et
Femasys Inc (FEMY) Institutional Confidence - TradingKey
Femasys Inc. (FEMY) Q1 2026 Earnings: Narrower Loss Drives Positive Surprise, Stock GainsROA Comparison - dars.gov.et
FEMY Q1 2026 Earnings: Narrower-than-expected loss drives 34.6% EPS surprise despite stock declineTangible Book Value - DonanımHaber
Femasys Inc. (FEMY) Slips 4% After Recent Rally; Key Support TestedLow Volatility Picks - dars.gov.et
Femasys Company Profile & Introduction - Moomoo
FEMYFemasys Inc Options - Finviz
FEMY Stock Price, Quote & Chart - ChartMill
FEMY Q1 2026 Earnings: EPS Surprises to the Upside Despite Narrowing LossesQuarterly Financial Update - dars.gov.et
FEMY Q1 2026 Earnings: EPS Beat Driven by Cost Discipline as Stock Declines SlightlyNet Profit Margin - DonanımHaber
Femasys Inc. (FEMY) Retreats 3.81%, Approaching Key Support Near $3.35EMA Signal - dars.gov.et
Femasys Shareholders Approve Directors and Auditor at Meeting - TipRanks
Femasys (FEMY) investors back directors and KPMG auditor at 2026 meeting - Stock Titan
Femasys Regains Nasdaq Compliance and Expands Global Access to Innovative Fertility and Birth Control Solutions - Minichart
Femasys regains Nasdaq compliance with minimum bid price rule - Investing.com
Femasys Regains Compliance With Nasdaq Minimum Bid Price Rule - Moomoo
Femasys regains compliance with Nasdaq - TipRanks
Femasys regains Nasdaq minimum bid compliance after 1-for-20 reverse split - TradingView
Femasys Regains Nasdaq Compliance After Reverse Stock Split - TipRanks
Femasys regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com South Africa
Femasys (NASDAQ: FEMY) back in compliance with Nasdaq listing requirements - Stock Titan
Femasys Regains Compliance with Nasdaq Listing Requirements - GlobeNewswire
Femasys regains Nasdaq compliance, focusing on advancing fertility and birth control innovations. - Pluang
Femasys, Inc. Stock Hits 52-Week Low at $4.50 Amid Challenges - MarketsMojo
Femasys, Inc. Stock Hits New 52-Week Low at $3.87 - MarketsMojo
Femasys Inc (FEMY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Femasys Inc (FEMY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Femasys Inc (FEMY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Femasys Inc (FEMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Femasys, Inc. Stock Plummets to New 52-Week Low of $3.77 - MarketsMojo
Femasys Inc (FEMY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Femasys Inc (FEMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Femasys Inc (FEMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Femasys Inc. (FEMY) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive SurpriseEarnings Revision Upgrade - newsline.com
Femasys Inc.: Target Price Consensus and Analysts Recommendations | FEMY | US31447E2046 - marketscreener.com
Femasys Inc.: Performance & Quotes, FEMY Stock Price on Nasdaq Exchange - marketscreener.com
Femasys Inc.: Fundamental Analysis and Financial Ratings | FEMY | US31447E2046 - marketscreener.com
Femasys Inc.: Financial Data Forecasts Estimates and Expectations | FEMY | US31447E2046 - marketscreener.com
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Beat Overshadowed by Revenue DisappointmentAnalyst Coverage Count - dars.gov.et
FEMY Q1 2026 Earnings: EPS Surprises to the Upside as Narrower Loss Drives Stock HigherBalance Sheet Strength - newsline.com
Femasys Inc. (FEMY) Edges Higher as Stock Tests Key Resistance LevelsWMA Signal - newsline.com
Femasys, Inc. Hits New 52-Week Low at $5.08 Amid Market Challenges - MarketsMojo
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Surprises to the Upside Despite Stock DeclineEstimate Dispersion - newsline.com
Femasys Inc. (FEMY) Shares Decline 14% as Price Tests Support Near $0.29Dark Pool Prints - newsline.com
Femasys Announces 1-for-20 Reverse Stock Split Implementation - TipRanks
Femasys (NASDAQ: FEMY) implements 1-for-20 reverse stock split - Stock Titan
Femasys Announces 1-for-20 Reverse Stock Split Initiative - The Globe and Mail
Femasys (FEMY) Slides 2.96% as Shares Test Key Support LevelVolume Spike Alerts - newsline.com
Femasys Inc Stock (FEMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.37%
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):